Clinical trials
Phase 2 Meningitis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 3 |
| 2004 | 3 |
| 2005 | 4 |
| 2006 | 2 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 3 |
| 2011 | 4 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 3 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 34 |
| Recruiting | 2 |
| Terminated | 2 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sanofi Pasteur, a Sanofi Company | 15 |
| Novartis Vaccines | 5 |
| GlaxoSmithKline | 4 |
| Astellas Pharma Inc | 1 |
| David Boulware | 1 |
| Hualan Biological Engineering, Inc. | 1 |
| JN-International Medical Corporation | 1 |
| MacroGenics | 1 |
| Milton S. Hershey Medical Center | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Meningitis | 40 |
| Meningococcal Infections | 24 |
| Meningitis, Meningococcal | 15 |
| Acquired Immunodeficiency Syndrome | 2 |
| Cryptococcosis | 2 |
| Meningitis, Cryptococcal | 2 |
| Meningoencephalitis | 2 |
| Tuberculosis, Meningeal | 2 |
| AIDS-Related Opportunistic Infections | 1 |
| Bacteremia | 1 |
Trials
Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.